Strategic DMPK input is a critical component in delivering high-quality drug discovery programmes and developing successful, robust drug candidates.
Our consultancy team works in close collaboration with internal experts to address key challenges and provide tailored solutions that maximise downstream success, particularly in the challenging drug discovery areas of CNS, heterobifunctional degraders and covalent inhibitors.
Our consultants are seasoned industry professionals with extensive experience across the drug discovery pipeline, including hit-to-lead, and lead optimisation stages. By integrating deep scientific insight with practical know-how, we help ensure that your drug discovery efforts, whether navigating early-stage discovery or refining advanced candidates are both efficient and effective.